Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 9/20 | 0.53 |
| ▸ | DRD5 | P21918 | 9/20 | 0.53 |
| ▸ | DRD2 | P14416 | 8/20 | 0.53 |
| ▸ | DRD3 | P35462 | 8/20 | 0.53 |
| ▸ | DRD4 | P21917 | 6/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.43 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.43 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6211902 | 0.95 | CHRM2 (0.49) | DRD1DRD5DRD2DRD3DRD4 | |
| SCHEMBL93622 | 0.89 | DRD1 (0.56) | DRD1DRD5DRD2DRD3DRD4 | |
| Hydrochloric Acid SCHEMBL11027184 | 0.87 | DRD1 (0.55) | DRD1DRD5DRD2DRD3DRD4 | |
| SCHEMBL3178012 | 0.85 | MEN1 (0.58) | DRD1DRD5DRD2DRD3DRD4 | |
| SCHEMBL2616323 | 0.79 | ALDH1A1 (0.60) | CHRM2CHRM4MEN1ALDH1A1GAA | |
| SCHEMBL24359312 | 0.78 | NOTUM (0.50) | DRD1DRD5DRD2DRD3DRD4 | |
| SCHEMBL520908 | 0.78 | BRD4 (0.51) | DRD1DRD2ESR2MEN1ALDH1A1 | |
| SCHEMBL19703497 | 0.78 | ALDH1A1 (0.46) | DRD1DRD5DRD2DRD3DRD4 | |
| SCHEMBL19002502 | 0.78 | ALDH1A1 (0.46) | CHRM2MEN1ALDH1A1GAAMAPT | |
| SCHEMBL31260115 | 0.78 | ALDH1A1 (0.46) | CHRM2MEN1ALDH1A1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022087624-A1 | COMPOUNDS AS RAS INHIBITORS AND USES THEREOF | BIOARDIS LLC (US) | 2022-04-28 | — | — | WO | disclosed |
| EP-3747885-A1 | HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2020-12-09 | — | — | EP | disclosed |
| US-20200140404-A1 | HETEROCYCLYL POLYMETHINE IR CHROMOPHORES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-05-07 | — | — | US | disclosed |
| EP-2675790-B1 | SUBSTITUTED 1, 2, 3, 4-TETRAHYDROQUINOLIN-7-YL CARBAMATES AS ACETYLCHOLINESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE | COUNCIL SCIENT IND RES (IN) | 2015-11-18 | — | — | EP | disclosed |
| US-8946261-B2 | Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of Alzheimer's disease | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-02-03 | — | — | US | disclosed |
| WO-2014063033-A2 | NOVEL PROBES AND TARGETING COMOUNDS FOR MITOCHONDRIA | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2014-04-24 | — | — | WO | disclosed |
| EP-2675790-A1 | SUBSTITUTED 1, 2, 3, 4-TETRAHYDROQUINOLIN-7-YL CARBAMATES AS ACETYLCHOLINESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE | Council of Scientific & Industrial Research (IN) | 2013-12-25 | — | — | EP | disclosed |
| US-20130324573-A1 | SUBSTITUTED 1, 2, 3, 4-TETRAHYDROQUINOLIN-7-YL CARBAMATES AS ACETYLCHOLINESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-12-05 | — | — | US | disclosed |
| WO-2012111021-A1 | SUBSTITUTED 1, 2, 3, 4-TETRAHYDROQUINOLIN-7-YL CARBAMATES AS ACETYLCHOLINESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETIES ACT (ACT XXI OF 1860) (IN) | 2012-08-23 | — | — | WO | disclosed |
| US-20120088916-A1 | OCTAHYDRO BIQUINOLINE COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2012-04-12 | — | — | US | disclosed |
| US-20070031336-A1 | 3H-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof | NOVARTIS AG (CH) | 2007-02-08 | — | — | US | disclosed |
| EP-1658294-B1 | 3H-PHENOXAZINE DERIVATIVES SUITABLE AS NEAR-INFRARED IMAGING AGENTS, PREPARATION AN USE THEREOF | NOVARTIS AG (CH) | 2007-01-10 | — | — | EP | disclosed |
| EP-1658294-A1 | 3H-PHENOXAZINE DERIVATIVES SUITABLE AS NEAR-INFRARED IMAGING AGENTS, PREPARATION AN USE THEREOF | Novartis AG (CH) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005016934-A1 | 3H-PHENOXAZINE DERIVATIVES SUITABLE AS NEAR-INFRARED IMAGING AGENTS, PREPARATION AN USE THEREOF | NOVARTIS AG (CH) | 2005-02-24 | — | — | WO | disclosed |
| US-6025505-A | FLUORESCENT LABELING PROBES FOR IMMUNOASSAYS, DNA SEQUENCING, DETECTING PRODUCTS OF POLYMERASE CHAIN REACTIONS | THE PERKIN-ELMER CORPORATION (US) | 2000-02-15 | — | — | US | disclosed |
| US-6017712-A | NUCLEOTIDE LABELED WITH XANTHENE DYE HAVING NARROWER EMISSION SPECTRUM AND WITH ABSORPTION SPECTRUM SHIFTED TO THE RED; FOR MOLECULAR PROBES AND IN NUCLEIC ACID SEQUENCING | APPLIED BIOSYSTEMS, LLC | 2000-01-25 | — | — | US | disclosed |
| US-5149807-A | Stability at certain wavelengths | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1992-09-22 | — | — | US | disclosed |
| US-4622400-A | SULFONATION, ALKALI FUSION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200140404-A1 | HETEROCYCLYL POLYMETHINE IR CHROMOPHORES | SMARCE1, SMARCD1, WDR82 | DRD1 674/4885DRD5 751/4885DRD2 962/4885 |
| US-20130324573-A1 | SUBSTITUTED 1, 2, 3, 4-TETRAHYDROQUINOLIN-7-YL CARBAMATES AS ACETYLCHOLINESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE | ACHE, BCHE, CHAT | DRD1 874/4885DRD5 1719/4885DRD2 846/4885 |
| US-20120088916-A1 | OCTAHYDRO BIQUINOLINE COMPOUND | CYP2S1, HCRTR2, CYP2B6 | DRD1 406/4885DRD5 660/4885DRD2 225/4885 |
| US-20070031336-A1 | 3H-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof | PSEN1, PSEN2, CHRM5 | DRD1 749/4885DRD5 255/4885DRD2 981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.